Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yiqi Huoxue method for chronic heart failure assessed by peak oxygen consumption
ChiCTR1800016247Phase 3Not yet recruiting
- Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Start
- Jul 2018
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Xinshuaifang granules in chronic heart failure (CHF) (2 arms), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoint: Peak oxygen consumption. Planned start Jul 2018; status: not yet recruiting.
02
Drugs
Xinshuaifang granules
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on ChiCTR1800016247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800016247.